These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22812695)

  • 41. The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer.
    Zhou Y; Wang M; Wu J; Jie Z; Chang S; Shuang T
    J Ovarian Res; 2015 Apr; 8():23. PubMed ID: 25887170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management.
    Lu L; Schwartz P; Scarampi L; Rutherford T; Canuto EM; Yu H; Katsaros D
    Gynecol Oncol; 2011 Aug; 122(2):366-71. PubMed ID: 21571355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Establishment of paclitaxel-resistant cell line and the underlying mechanism on drug resistance.
    Zhang J; Zhao J; Zhang W; Liu G; Yin D; Li J; Zhang S; Li H
    Int J Gynecol Cancer; 2012 Nov; 22(9):1450-6. PubMed ID: 23051955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells.
    Masuyama H; Nakamura K; Nobumoto E; Hiramatsu Y
    Int J Oncol; 2016 Sep; 49(3):1211-20. PubMed ID: 27572875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel.
    Kar R; Palanichamy JK; Banerjee A; Chattopadhyay P; Jain SK; Singh N
    Clin Transl Oncol; 2015 Sep; 17(9):737-42. PubMed ID: 26033427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
    Gan CZ; Li G; Luo QS; Li HM
    IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cells.
    Du F; Wu X; Liu Y; Wang T; Qi X; Mao Y; Jiang L; Zhu Y; Chen Y; Zhu R; Han X; Jin J; Ma X; Hua D
    Oncol Rep; 2013 Sep; 30(3):1113-8. PubMed ID: 23807572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation.
    Cai G; Ma X; Chen B; Huang Y; Liu S; Yang H; Zou W
    Tumour Biol; 2016 Sep; 37(9):11883-11891. PubMed ID: 27059733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer.
    Chen L; Liang L; Yan X; Liu N; Gong L; Pan S; Lin F; Zhang Q; Zhao H; Zheng F
    Int J Gynecol Cancer; 2013 Feb; 23(2):256-63. PubMed ID: 23358177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer.
    Wang H; Fan L; Xia X; Rao Y; Ma Q; Yang J; Lu Y; Wang C; Ma D; Huang X
    Int J Gynecol Cancer; 2012 Jun; 22(5):755-61. PubMed ID: 22635028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis.
    Wang J; Ye C; Liu J; Hu Y
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1034-1040. PubMed ID: 29777711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
    Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
    Zhang L; Li Z; Gai F; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancer.
    Yan BX; Ma JX; Zhang J; Guo Y; Riedel H; Mueller MD; Remick SC; Yu JJ
    Oncogene; 2014 Nov; 33(45):5288-94. PubMed ID: 24186202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88.
    Zhan Y; Xiang F; Wu R; Xu J; Ni Z; Jiang J; Kang X
    J Ovarian Res; 2015 Jul; 8():48. PubMed ID: 26223974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
    Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G
    Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.
    Lv K; Liu L; Wang L; Yu J; Liu X; Cheng Y; Dong M; Teng R; Wu L; Fu P; Deng W; Hu W; Teng L
    PLoS One; 2012; 7(7):e40008. PubMed ID: 22808086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization.
    Wu YH; Chang TH; Huang YF; Chen CC; Chou CY
    Oncotarget; 2015 Sep; 6(27):23748-63. PubMed ID: 26087191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.